Miltefosine: issues to be addressed in the future.

Berman, J; Bryceson, A D M; Croft, S; Engel, J; Gutteridge, W; Karbwang, J; Sindermann, H; Soto, J; Sundar, S; Urbina, J A

Berman, J; Bryceson, A D M; Croft, S; Engel, J; Gutteridge, W; Karbwang, J; Sindermann, H; Soto, J; Sundar, S; Urbina, J A.

Affiliation

Berman J; bermanjo@mail.nih.gov

Trans R Soc Trop Med Hyg ; 100 Suppl 1: S41-4, 2006 Dec.

Article in En | MEDLINE | ID: mdl-16750231

Subject(s)

Antiprotozoal Agents/therapeutic use; Leishmaniasis/drug therapy; Phosphorylcholine/analogs & derivatives; Abnormalities, Drug-Induced/prevention & control; Drug Resistance; Female; Forecasting; HIV Infections/complications; Humans; Leishmaniasis/complications; Phosphorylcholine/therapeutic use; Pregnancy; Pregnancy Complications, Parasitic/drug therapy

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Phosphorylcholine / Leishmaniasis / Antiprotozoal Agents Type of study: Prognostic_studies Limits: Female / Humans / Pregnancy Language: En Year: 2006 Type: Article

Search on Google

XML

PubMed Links